See more : EVE Health Group Limited (EVE.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Earth Science Tech, Inc. (ETST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Earth Science Tech, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Perpetual Limited (PPT.AX) Income Statement Analysis – Financial Results
- Amed Co., Ltd. (7575.TWO) Income Statement Analysis – Financial Results
- China Health Group Limited (0673.HK) Income Statement Analysis – Financial Results
- Genting Malaysia Berhad (4715.KL) Income Statement Analysis – Financial Results
- UTI Asset Management Company Limited (UTIAMC.NS) Income Statement Analysis – Financial Results
Earth Science Tech, Inc. (ETST)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.earthsciencetech.com
About Earth Science Tech, Inc.
Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. Its products include hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs through its retail store, clinics, pharmacies, as well as through online. It also provides medical equipment and devices. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. The company was incorporated in 2010 and is headquartered in Doral, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.95M | 48.54K | 14.12K | 140.90K | 526.14K | 770.64K | 463.11K | 428.20K | 469.45K | 80.28K | 7.45K | 41.89K | 22.42K |
| Cost of Revenue | 4.13M | 26.48K | 22.64K | 100.97K | 307.67K | 475.62K | 270.22K | 243.81K | 341.91K | 77.06K | 900.00 | 6.76K | 3.60K |
| Gross Profit | 7.83M | 22.06K | -8.52K | 39.93K | 218.47K | 295.01K | 192.89K | 184.39K | 127.53K | 3.22K | 6.55K | 35.13K | 18.82K |
| Gross Profit Ratio | 65.49% | 45.45% | -60.30% | 28.34% | 41.52% | 38.28% | 41.65% | 43.06% | 27.17% | 4.01% | 87.92% | 83.86% | 83.94% |
| Research & Development | 0.00 | 0.00 | 0.00 | 9.00K | 76.11K | 338.86K | 150.45K | 0.00 | 0.00 | 32.59K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.32M | 933.18K | 202.09K | 464.08K | 919.08K | 1.33M | 1.20M | 1.25M | 426.99K | 8.07M | 46.27K | 91.43K | 41.60K |
| Selling & Marketing | 25.28K | 8.07K | 3.66K | 0.00 | 47.07K | 242.72K | 332.99K | 77.86K | 49.37K | 414.22K | 0.00 | 5.20K | 0.00 |
| SG&A | 6.36M | 941.25K | 205.75K | 464.08K | 966.15K | 1.58M | 1.53M | 1.33M | 785.28K | 8.48M | 46.27K | 96.63K | 41.60K |
| Other Expenses | 579.26K | 31.35K | 3.45M | 407.00 | 26.35K | 690.94K | 122.84K | 0.00 | 0.00 | 430.94K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.94M | 972.60K | 205.75K | 473.08K | 1.04M | 1.92M | 1.80M | 1.33M | 785.28K | 8.51M | 46.27K | 96.63K | 41.60K |
| Cost & Expenses | 11.06M | 999.08K | 228.39K | 574.04K | 1.35M | 2.39M | 2.08M | 1.57M | 1.13M | 8.59M | 47.17K | 103.39K | 45.20K |
| Interest Income | 0.00 | 47.43K | 86.71K | 81.47K | 318.04K | 75.63K | 0.00 | 3.00 | 4.73K | 122.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 67.21K | 47.43K | 86.71K | 81.47K | 317.74K | 75.63K | 4.77K | 4.77K | 0.00 | 4.73K | 106.00 | 525.00 | 77.00 |
| Depreciation & Amortization | 149.75K | 17.49K | 2.42K | 2.42K | 7.23K | 11.53K | 23.53K | 12.44K | 13.16K | 4.48K | -106.00 | -525.00 | -77.00 |
| EBITDA | 1.04M | -300.48K | -224.29K | -4.30M | -874.99K | -2.13M | -1.69M | -1.13M | -1.20M | -8.76M | -12.54M | -62.02K | -22.86K |
| EBITDA Ratio | 8.72% | -619.08% | 23,170.79% | -305.40% | -150.19% | -208.80% | -343.02% | -263.70% | -137.31% | -10,596.19% | -531.69% | -145.58% | -101.24% |
| Operating Income | 892.35K | -950.54K | -214.26K | -433.14K | -823.79K | -1.62M | -1.61M | -10.14M | -657.75K | -8.51M | -39.72K | -61.50K | -22.78K |
| Operating Income Ratio | 7.47% | -1,958.39% | -1,517.11% | -307.41% | -156.57% | -210.30% | -348.10% | -2,368.43% | -140.11% | -10,601.93% | -533.11% | -146.83% | -101.58% |
| Total Other Income/Expenses | -67.21K | 571.28K | 3.40M | -81.06K | -291.69K | -75.63K | -101.56K | -4.77K | -565.12K | -4.61K | -106.00 | -525.00 | -77.00 |
| Income Before Tax | 825.14K | -379.27K | 3.17M | -4.38M | -1.20M | -2.22M | -1.68M | -1.15M | -1.22M | -8.52M | -39.82K | -62.03K | -22.85K |
| Income Before Tax Ratio | 6.90% | -781.40% | 22,468.74% | -3,110.80% | -228.07% | -287.47% | -362.26% | -267.72% | -260.49% | -10,607.67% | -534.54% | -148.08% | -101.92% |
| Income Tax Expense | 13.00K | -523.85K | -3.49M | 81.87K | 344.09K | 519.10K | 60.79K | 4.77K | 5.00 | 4.61K | 106.00 | 525.00 | 77.00 |
| Net Income | 812.14K | 144.58K | 6.66M | -4.47M | -1.54M | -2.22M | -1.74M | -1.15M | -1.22M | -8.52M | -39.82K | -62.03K | -22.85K |
| Net Income Ratio | 6.79% | 297.87% | 47,156.64% | -3,168.90% | -293.47% | -287.47% | -375.38% | -267.72% | -260.49% | -10,607.67% | -534.54% | -148.08% | -101.92% |
| EPS | 0.00 | 0.00 | 0.12 | -0.09 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 | -0.23 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.12 | -0.09 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 | -0.23 | 0.00 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 309.69M | 145.87M | 53.85M | 50.88M | 40.01M | 55.38M | 42.84M | 38.21M | 38.70M | 36.84M | 10.76M | 9.49M | 6.70M |
| Weighted Avg Shares Out (Dil) | 309.69M | 145.87M | 53.85M | 50.88M | 40.01M | 55.38M | 42.84M | 38.21M | 38.70M | 36.84M | 10.76M | 9.49M | 6.70M |
Earth Science Tech, Inc., Reports its June 30, 2024, Quarter Results, Recording Over $8.5M in Revenue and $1.07M in Net Profit
Earth Science Tech, Inc., Reports its March 31, 2024, Annual Results, Recording Over $11.9M in Revenue
Earth Science Tech, Inc., Shares an Annual Letter from the CEO for the Company's Fiscal March 31, 2024, Year End
Earth Science Tech, Inc., Announces $5 Million Common Stock Repurchase Program
Earth Science Tech, Inc., Reports Fiscal Q2 2023 Financial Results, Recording Over $1.9M in Revenue for the Quarter
Earth Science Tech, Inc. Launches DocProtocol.com
Earth Science Tech, Inc., Reports Record Fiscal Q1 2023 Financial Results
Earth Science Tech, Inc., Appoints New CFO and Shares that RxCompoundStore.com, LLC. has Received Approval to Ship into Additional States
Earth Science Tech, Inc. (ETST) Q2 2023 Earnings Call Transcript
Earth Science Tech, Inc. (ETST) Announces Second Quarter Fiscal 2023 Financial Results on November 14, 2022, Followed with an Updated Conference Call and Webcast
Source: https://incomestatements.info
Category: Stock Reports